News
Recent findings on the role and potential of L. reuteri in the therapy of GIT diseases
Probiotics contain bacterial or yeast strains similar to beneficial types naturally occurring in the human gastrointestinal tract. Their role in the therapy of gastrointestinal diseases has been extensively researched, demonstrating significant effects on a number of nosological units. One modality of probiotic therapy involves the administration of the bacteria L. reuteri, specifically the laboratory-modified strain DSM 17938.
ESC 2022: Can Modern Treatment of Acute Heart Failure Improve (Re)hospitalization Prevention?
Heart failure (HF) and the possibilities of its therapy were one of the frequently discussed topics…
Diagnosis of AHA Requires Laboratory Testing – What Are Its Key Specifics?
Acquired hemophilia A (AHA) is a rare but very serious disease with a high mortality rate. Quick…
The Importance of Hydration in Wound Healing
In response to skin injury, bodily processes initiate to restore the function of the skin barrier,…
ESC 2022: What Current Insights Say About the Role of Dabigatran in Stroke Prevention with Atrial Fibrillation and Comorbidities
The risk of atrial fibrillation (AF) increases with age as risk factors accumulate and…
ESC 2022: How to use gliflozins in heart failure? American guidelines now also consider the EMPEROR-Preserved study
One of the important current cardiology topics is the possibility of using gliflozins in patients…
Effectiveness of Dietary Intervention in Irritable Bowel Syndrome – Results of a Network Meta-Analysis
A low FODMAP diet is often recommended to alleviate symptoms of irritable bowel syndrome (IBS).…
Aloe vera Extract in the Therapy of Irritable Bowel Syndrome
The therapy options for irritable bowel syndrome are relatively limited, thus complementary and…
Cognitive changes in MS – what can teriflunomide do?
In Phase III clinical trials, teriflunomide demonstrated its ability to slow down brain tissue…
To Vaccinate or Not to Vaccinate? That’s the Question for MS and COVID-19
What is the response of patients with multiple sclerosis (MS) to vaccination against COVID-19…